Invasive Fungal Infections
📧 Sign up to get email alerts when something new happens for Invasive Fungal Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Study on the Pharmacokinetic Characteristics of Liposomal Amphotericin B in Patients With Invasive Fungal Infections Undergoing Plasma Exchange Therapy
A clinical trial update describing the pharmacokinetic characteristics of liposomal amphotericin B in patients with invasive fungal infectio…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Human Bioequivalence Study of Liposomal Amphotericin B for Injection [NA]
This document reports a human bioequivalence study of liposomal amphotericin B for injection that is currently active but not recruiting, sp…
-
CLINICAL_TRIALS trial_result · 2025-12-12Clinical Trial Update: Biodistribution and Pathophysiology Study of 18F-Fluorodeoxysorbitol (18F-FDS) in Diseased Patients
A completed clinical trial assessing the biodistribution and pathophysiology of the radiotracer 18F-FDS in diseased patients. The study enco…
-
CLINICAL_TRIALS trial_result · 2025-12-09Clinical Trial Update: Performance Evaluation of the Fujifilm Wako Beta-D-glucan Technique in the Diagnosis of Major Invasive Fungal Infections (IFI)
This clinical trial update evaluates the performance of the Fujifilm Wako beta-D-glucan assay in diagnosing major invasive fungal infections…
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: Human Bioequivalence Study of Amphotericin B Liposome for Injection [NA]
Completed a human bioequivalence study of liposomal amphotericin B for injection.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: Siderophore-labelled Positron Emission Tomography for Correlating Invasive Fungal InfeCtions
A clinical trial update on a siderophore-labelled PET tracer being investigated to image invasive fungal infections. The study is currently …
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: Hyperbaric Oxygen Therapy Used on Severely Injured Healthy Individuals With Fungal Infections
A clinical trial evaluating hyperbaric oxygen therapy for invasive fungal infections is active but not recruiting, sponsored by Assaf-Harofe…
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: Expanded Access to Fosmanogepix for Patients With Serious or Life-threatening Invasive Fungal Infections
Expanded access (compassionate use) for fosmanogepix is being offered to patients with serious or life-threatening invasive fungal infection…
-
FDA approval · 2025-07-03FDA Approved: POSACONAZOLE — Supplemental Application (GLENMARK PHARMACEUTICALS INC., USA)
FDA approved a supplemental application for posaconazole submitted by Glenmark Pharmaceuticals Inc., USA, under an ANDA.
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Anti-fungal Strategies in Acute-on-Chronic Liver Failure Patients [NA]
This clinical trial update reports the completion of a study evaluating anti-fungal strategies in patients with acute-on-chronic liver failu…
-
CLINICAL_TRIALS research · 2025-05-04Clinical Trial Update: L-AmB_ Retrospective mUlticenter Study on Mycosis prOphylaxis
This clinical trial entry describes an ongoing multicenter retrospective study evaluating liposomal amphotericin B (L-AmB) for prophylaxis a…
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: Breath Analysis for the Detection of Invasive Fungal Infections
This clinical trial update describes a breath analysis approach being studied to detect invasive fungal infections in patients with leukemia…
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: Rezafungin Paediatric PK Study in Paediatric Subjects From Birth to <18 Years of Age [Phase 1]
This update covers a pediatric pharmacokinetic study of rezafungin in children from birth to under 18 years with invasive fungal infections,…
-
FDA approval · 2025-03-13FDA Approved: POSACONAZOLE — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for posaconazole from Mylan Institutional LLC, updating the approval for the generic product.
-
CLINICAL_TRIALS trial_result · 2024-12-31Clinical Trial Update: Population Pharmacokinetics of L-AmB in Chinese Patients Assisted by Extracorporeal Membrane Pulmonary Oxygenation (ECMO) [Phase 4]
Phase 4 clinical trial update on the population pharmacokinetics of liposomal amphotericin B (L-AmB) in Chinese patients supported by ECMO f…
-
FDA approval · 2024-12-23FDA Approved: POSACONAZOLE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' posaconazole under an Original Application (ANDA), marking a generic approval for this antifungal.
-
CLINICAL_TRIALS trial_result · 2024-11-14Clinical Trial Update: Invasive Fungal Infections in Patients Following Stem Cell Transplant
This is a completed clinical trial investigating invasive fungal infections in patients following stem cell transplantation.
-
CLINICAL_TRIALS research · 2024-11-06Clinical Trial Update: Usefulness of PET-CT for Invasive Fungal Infection
A clinical trial evaluating the usefulness of PET-CT for invasive fungal infections is currently recruiting.
-
FDA approval · 2024-10-24FDA Approved: POSACONAZOLE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s supplemental application for posaconazole (POSACONAZOLE), approving the generic product.
-
CLINICAL_TRIALS trial_result · 2024-10-21Clinical Trial Update: Non-interventional Study for Prevention and Treatment of Fungal Infections in Paediatric Patients in Asia/Oceania - ERADICATE Study
A non-interventional pediatric study in Asia/Oceania evaluating prevention and treatment of invasive fungal infections has completed.
-
CLINICAL_TRIALS other · 2024-07-12Clinical Trial Update: Retrospective Study of Invasive Fungal Infections With Filamentous Fungi in Heart Transplant Patients
A retrospective study evaluating invasive fungal infections caused by filamentous fungi in heart transplant patients, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-07-10Clinical Trial Update: Evaluate F901318 (Olorofim) Treatment of Invasive Fungal Infections in Participants Lacking Treatment Options [Phase 2]
Phase 2 trial evaluating olorofim (F901318) for invasive fungal infections in participants with no remaining treatment options has completed…
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: Pharmacokinetics of Liposomal Amphotericin B in Critically Ill vs. Non-critically Ill Hematological Patients: Exploration of Covariates
A clinical trial update investigating the pharmacokinetics of liposomal amphotericin B in critically ill versus non-critically ill hematolog…
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Micafungin Versus Amphotercine B in Treatment of Invasive Fungal Infection [Phase 4]
A Phase 4 trial comparing micafungin to amphotericin B in neonatal invasive fungal infections has completed.
-
FDA approval · 2023-08-28FDA Approved: POSACONAZOLE — Original Application (i3 Pharmaceuticals, LLC)
FDA approved an original application for posaconazole from i3 Pharmaceuticals, LLC (generic posaconazole).